Introducing iHOPE—the scientifically validated app that precisely predicts the likelihood of live birth following genetically tested single embryo transfer. Built from extensive research on over 2,700 pregnancy cases from leading IVF clinics, iHOPE provides personalized, evidence-based predictions using initial and repeated hCG measurements. Clinicians and patients can now manage expectations realistically and monitor early pregnancy progress effectively. With robust external validation, iHOPE ensures accuracy across diverse fertility practices globally. Navigate the complexities of early pregnancy monitoring with confidence. Trust the science, trust iHOPE. To use iHOPE you need at least two beta-HCG (pregnancy test) results that are at least a day apart. Key Features: Accurate, personalized live birth probability assessments Unique reference ranges for PGT-A-tested embryos Supports clinical decisions and patient counseling Validated extensively in international fertility clinics Easy-to-use interface for quick, clear insights Empower your fertility journey with reliable predictions—download iHOPE today.